A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
University of Southern California
University of Virginia
National Institutes of Health Clinical Center (CC)
NRG Oncology
Elevation Oncology
Valerio Therapeutics
Tango Therapeutics, Inc.
Pfizer
Haihe Biopharma Co., Ltd.
OHSU Knight Cancer Institute
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
Centre Hospitalier Universitaire de Besancon
pharmaand GmbH
Nuvation Bio Inc.
Eastern Cooperative Oncology Group
West Virginia University
Duke University
National Institutes of Health Clinical Center (CC)
MacroGenics
Advanced Accelerator Applications
National Institutes of Health Clinical Center (CC)
Tetra Bio-Pharma
InSightec
Cambridge University Hospitals NHS Foundation Trust
Scripps Translational Science Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Vanderbilt-Ingram Cancer Center
Seagen Inc.
Yale University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
CureOne
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Vanderbilt-Ingram Cancer Center
University of Pittsburgh
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute